Partial reversal of the in vivo antimalarial activity of DDS against Plasmodium berghei by induced hyperglycemia.
D000284:Administration, Oral; D000496:Alloxan; D000818:Animals; D000962:Antimalarials / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000032:analysis; D003622:Dapsone / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D004912:Erythrocytes / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced / Q000503:physiopathology*; D008288:Malaria / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D008297:Male; D051379:Mice; D010961:Plasmodium / Q000187:drug effects
D000962:Antimalarials; D001786:Blood Glucose; D000496:Alloxan; D003622:Dapsone; D005947:Glucose